| 1 |
35062050 | CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver. | 2022 Feb |
1 |
| 2 |
35426132 | The Impact of CYP2C9*11 Allelic Variant on the Pharmacokinetics of Phenytoin and (S)-Warfarin. | 2022 Jul |
3 |
| 3 |
35590072 | Exome sequencing allows detection of relevant pharmacogenetic variants in epileptic patients. | 2022 May 19 |
1 |
| 4 |
35629204 | Frequency of CYP2C9 Promoter Variable Number Tandem Repeat Polymorphism in a Spanish Population: Linkage Disequilibrium with CYP2C9*3 Allele. | 2022 May 12 |
1 |
| 5 |
32779747 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update. | 2021 Feb |
2 |
| 6 |
33961833 | Risk prediction of drug-drug interaction potential of phenytoin and miconazole topical formulations. | 2021 Jul 1 |
2 |
| 7 |
34060344 | A meta-analysis of effects of CYP2C9 and CYP2C19 polymorphisms on phenytoin pharmacokinetic parameters. | 2021 Jul |
3 |
| 8 |
34109627 | PharmVar GeneFocus: CYP2C9. | 2021 Sep |
1 |
| 9 |
34429480 | Impact of genetic and non-genetic factors on hepatic CYP2C9 expression and activity in Hungarian subjects. | 2021 Aug 24 |
1 |
| 10 |
31646624 | HLA-B*51:01 and CYP2C9*3 Are Risk Factors for Phenytoin-Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project. | 2020 May |
4 |
| 11 |
31938857 | Phenytoin intoxication associated with omeprazole administration in a child with defective CYP2C9. | 2020 May |
3 |
| 12 |
32216088 | Associations of CYP2C9 and CYP2C19 Pharmacogenetic Variation with Phenytoin-Induced Cutaneous Adverse Drug Reactions. | 2020 Sep |
3 |
| 13 |
32423989 | Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native People. | 2020 Aug |
1 |
| 14 |
32457604 | Possible Genetic Determinants of Response to Phenytoin in a Group of Colombian Patients With Epilepsy. | 2020 |
1 |
| 15 |
32510242 | An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects. | 2020 Aug |
5 |
| 16 |
33071782 | Comparison of CYP2C9 Activity in Ethiopian and Non-Ethiopian Jews Using Phenytoin as a Probe. | 2020 |
2 |
| 17 |
33967488 | How genetic variation was analyzed in phenytoin-induced gingival enlargement using single-nucleotide polymorphism of candidate gene CYP2C9? | 2020 Sep-Dec |
2 |
| 18 |
30270535 | HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians. | 2019 Feb |
4 |
| 19 |
31206740 | High and variable population prevalence of HLA-B*56:02 in indigenous Australians and relation to phenytoin-associated drug reaction with eosinophilia and systemic symptoms. | 2019 Sep |
1 |
| 20 |
31461080 | Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system. | 2019 Oct |
4 |
| 21 |
29274302 | Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis. | 2018 Jun |
5 |
| 22 |
29628024 | The association between CYP2C9/2C19 polymorphisms and phenytoin maintenance doses in Asian epileptic patients: A systematic review and meta-analysis
. | 2018 Jul |
5 |
| 23 |
29636628 | CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment. | 2018 |
5 |
| 24 |
30135636 | The role of pharmacogenetics of cytochrome P450s in phenytoin-induced DRESS syndrome. | 2018 |
1 |
| 25 |
30283820 | DRESS after IV phenytoin associated with cytochrome P450 CYP2C9*3 homozygosity. | 2018 Oct |
1 |
| 26 |
28302415 | A prospective study to assess the association between genotype, phenotype and Prakriti in individuals on phenytoin monotherapy. | 2017 Jan - Mar |
1 |
| 27 |
28748348 | Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region. | 2017 Sep |
1 |
| 28 |
28820457 | Role of CYP2C9, CYP2C19 and EPHX Polymorphism in the Pharmacokinetic of Phenytoin: A Study on Uruguayan Caucasian Subjects. | 2017 Aug 18 |
3 |
| 29 |
29472822 | Presence of a single nucleotide polymorphism (RS3758581) in a boy with DRESS syndrome. | 2017 |
1 |
| 30 |
25998968 | Phenytoin toxicity in two-month-old Thai infant with CYP2C9 gene polymorphism--A case report. | 2016 Jan |
3 |
| 31 |
26122019 | CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy. | 2016 Jun |
1 |
| 32 |
26658169 | Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations. | 2016 Jan |
1 |
| 33 |
26928377 | Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population. | 2016 May |
3 |
| 34 |
27154258 | Severe cutaneous adverse drug reactions. | 2016 Jul |
1 |
| 35 |
27163851 | In vitro metabolism of phenytoin in 36 CYP2C9 variants found in the Chinese population. | 2016 Jun 25 |
8 |
| 36 |
27174459 | Population Pharmacokinetics of Phenytoin Based on NONMEM in Patients with Intracranial Tumor During the First Week of Post-Craniotomy. | 2016 |
1 |
| 37 |
27179628 | Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy. | 2016 May 14 |
3 |
| 38 |
27390048 | Pharmacokinetic model analysis of interaction between phenytoin and capecitabine. | 2016 Sep |
1 |
| 39 |
25162219 | Individualized phenytoin therapy for Japanese pediatric patients with epilepsy based on CYP2C9 and CYP2C19 genotypes. | 2015 Apr |
3 |
| 40 |
25311916 | The effect of polymorphic metabolism enzymes on serum phenytoin level. | 2015 Mar |
1 |
| 41 |
25597548 | Use of multi-dose activated charcoal in phenytoin toxicity secondary to genetic polymorphism. | 2015 Feb |
1 |
| 42 |
25681367 | [A case of phenytoin intoxication caused by interaction between phenytoin and capecitabine]. | 2015 Feb |
1 |
| 43 |
25943175 | Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance. | 2015 Jul |
3 |
| 44 |
25994870 | Association analysis of CYP2C9*3 and phenytoin-induced severe cutaneous adverse reactions (SCARs) in Thai epilepsy children. | 2015 Aug |
5 |
| 45 |
26037375 | CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects. | 2015 |
5 |
| 46 |
26179835 | Potentially Unsafe Herb-drug Interactions Between a Commercial Product of Noni Juice and Phenytoin- A Case Report. | 2015 Jun |
1 |
| 47 |
24530212 | Influence of CYP2C9 polymorphism and phenytoin co-administration on acenocoumarol dose in patients with cerebral venous thrombosis. | 2014 May |
1 |
| 48 |
24825094 | Molecular functionality of CYP2C9 polymorphisms and their influence on drug therapy. | 2014 |
1 |
| 49 |
25096692 | Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. | 2014 Aug 6 |
5 |
| 50 |
25099164 | Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing. | 2014 Nov |
3 |